Literature DB >> 21727917

Arterial thrombus formation in cardiovascular disease.

Giuseppe Lippi1, Massimo Franchini, Giovanni Targher.   

Abstract

The pathogenesis of arterial thrombosis is complex and dynamic. Unlike venous thrombi, arterial thrombi typically form under conditions of high blood flow and are mainly composed of platelet aggregates, giving them the appearance of 'white clots'. Strong evidence suggests that arterial thrombi originate as a consequence of an injured atherosclerotic plaque, and that their formation involves the release of prothrombotic material (such as tissue factor), platelet aggregation, and platelet adhesion to the vascular wall. The initially labile platelet plaque is then stabilized by insoluble fibrin produced upon activation of the coagulation cascade. Inherited genetic factors (gene polymorphisms) and acquired predisposing conditions (such as the concentration and activity of clotting factors) can influence both the composition and the size of an arterial thrombus. Further research is needed to elucidate the functions of blood coagulation proteins and cellular elements that are critical to the pathogenesis of arterial thrombosis. This Review explains mechanisms of pathological arterial thrombus formation and discusses genetic and acquired risk factors of atherothrombosis.

Entities:  

Mesh:

Year:  2011        PMID: 21727917     DOI: 10.1038/nrcardio.2011.91

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  122 in total

1.  WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

Authors:  E W DAVIE; O D RATNOFF
Journal:  Science       Date:  1964-09-18       Impact factor: 47.728

Review 2.  Platelets as immune cells: bridging inflammation and cardiovascular disease.

Authors:  Philipp von Hundelshausen; Christian Weber
Journal:  Circ Res       Date:  2007-01-05       Impact factor: 17.367

Review 3.  Challenges and promises of developing thrombin receptor antagonists.

Authors:  Jing Yang; Ke Xu; Dietmar Seiffert
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2010-11

Review 4.  Role of adipose tissue in haemostasis, coagulation and fibrinolysis.

Authors:  D R Faber; Ph G de Groot; F L J Visseren
Journal:  Obes Rev       Date:  2009-05-12       Impact factor: 9.213

5.  Contemporary approaches to gene discovery: progress toward personalized medicine?

Authors:  Ingrid B Borecki
Journal:  Circ Cardiovasc Genet       Date:  2009-02

6.  Polymorphisms of platelet membrane glycoprotein Ib alpha and plasma von Willebrand factor antigen in coronary artery disease.

Authors:  T Ito; F Ishida; S Shimodaira; K Kitano
Journal:  Int J Hematol       Date:  1999-07       Impact factor: 2.490

7.  Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice.

Authors:  Arunima Ghosh; Wei Li; Maria Febbraio; Ricardo G Espinola; Keith R McCrae; Erin Cockrell; Roy L Silverstein
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 8.  Venous and arterial thrombosis: different sides of the same coin?

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Eur J Intern Med       Date:  2008-03-20       Impact factor: 4.487

9.  SNPs in BRAP associated with risk of myocardial infarction in Asian populations.

Authors:  Kouichi Ozaki; Hiroshi Sato; Katsumi Inoue; Tatsuhiko Tsunoda; Yasuhiko Sakata; Hiroya Mizuno; Tsung-Hsien Lin; Yoshinari Miyamoto; Asako Aoki; Yoshihiro Onouchi; Sheng-Hsiung Sheu; Shiro Ikegawa; Keita Odashiro; Masakiyo Nobuyoshi; Suh-Hang H Juo; Masatsugu Hori; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Nat Genet       Date:  2009-02-08       Impact factor: 38.330

10.  Defective thrombus formation in mice lacking coagulation factor XII.

Authors:  Thomas Renné; Miroslava Pozgajová; Sabine Grüner; Kai Schuh; Hans-Ulrich Pauer; Peter Burfeind; David Gailani; Bernhard Nieswandt
Journal:  J Exp Med       Date:  2005-07-11       Impact factor: 14.307

View more
  67 in total

1.  Erythropoietin and myocardial infarction.

Authors:  Fabian Sanchis-Gomar; Vladimir E Martinez-Bello; Giuseppe Lippi
Journal:  Clin Transl Sci       Date:  2011-11-22       Impact factor: 4.689

Review 2.  Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.

Authors:  Qudsia Rashid; Poonam Singh; Mohammad Abid; Mohamad Aman Jairajpuri
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

Review 3.  Paradoxical thrombosis, part 2: anticoagulant and antiplatelet therapy.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

Review 4.  Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

5.  Injury measurements improve interpretation of thrombus formation data in the cremaster arteriole laser-induced injury model of thrombosis.

Authors:  Steven P Grover; Pavan K Bendapudi; Moua Yang; Glenn Merrill-Skoloff; Vijay Govindarajan; Alexander Y Mitrophanov; Robert Flaumenhaft
Journal:  J Thromb Haemost       Date:  2020-10-29       Impact factor: 5.824

6.  Rapid assembly and profiling of an anticoagulant sulfoprotein library.

Authors:  Emma E Watson; Jorge Ripoll-Rozada; Ashley C Lee; Mike C L Wu; Charlotte Franck; Tim Pasch; Bhavesh Premdjee; Jessica Sayers; Maria F Pinto; Pedro M Martins; Shaun P Jackson; Pedro José Barbosa Pereira; Richard J Payne
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-20       Impact factor: 11.205

7.  The interplay between genetics, epigenetics and environment in modulating the risk of coronary heart disease.

Authors:  Giuseppe Lippi; Gianfranco Cervellin
Journal:  Ann Transl Med       Date:  2016-12

8.  Translation from the data of clinical trials to precision medicine: limitation of the current risk score for predicting coronary thrombosis and major bleeding.

Authors:  Jong-Hwa Ahn; Jeong Yoon Jang; Young-Hoon Jeong
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

9.  Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis.

Authors:  Christa L Pawlowski; Wei Li; Michael Sun; Kavya Ravichandran; DaShawn Hickman; Clarissa Kos; Gurbani Kaur; Anirban Sen Gupta
Journal:  Biomaterials       Date:  2017-03-14       Impact factor: 12.479

Review 10.  The biology behind the atherothrombotic effects of cigarette smoke.

Authors:  Adam Csordas; David Bernhard
Journal:  Nat Rev Cardiol       Date:  2013-02-05       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.